Principal Investigator
Amer Beitinjaneh
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20210259
Clinical Trial Summary
Expanded Access Protocol (EAP) for Subjects Receiving Lisocabtagene Maraleucel that is Nonconforming for Commercial Release
Phase
N/A
Funding Agency/Sponsor
Industrial
Disease
Lymphoma
Contact Information
Phone Number
305-243-2647